Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment.

INTRODUCTION/PURPOSE Surgery and postoperative radiotherapy (XRT) is a standard therapy for locally advanced resectable oropharyngeal carcinoma. This maximizes local-regional control, but does not address the potential for occult distant metastases. Additionally, some patients may suffer poor functional outcome after this intensive local therapy. This report reviews our institutional experience with modern radical surgery and XRT for this disease. METHODS A retrospective chart review was performed on 51 consecutive patients treated from 1991 to 1997 at the University of Pennsylvania with radical surgery and postoperative XRT. This study included patients with locally advanced, stage III/IV (exclusive of T1-2N1) squamous carcinoma of the oropharynx. All patients had a good performance status (ECOG 0-1). Patients who received adjuvant chemotherapy were excluded. No patient had gross residual disease after surgery; the median XRT dose was 63.7 Gy. Survival, local-regional control (LRC), and freedom from distant metastases (DM) were calculated actuarially. In patients who remained free of disease, functional status was determined using the List Performance Status Scale (PSS). RESULTS With a median follow-up in surviving patients of 34 months, the 3-year actuarial overall survival was 51%. The 3-year LRC was 73%, and the freedom from DM was 69%. The most significant factor predicting for failure was the number of pathologically positive nodes (P <.001 for survival and DM; P =.003 for LRC). In 29 patients who were evaluable for the List PSS, the mean normalcy-of-diet score was 48; the mean eating-in-public score was 53; and the mean understandability-of-speech score was 75. There was a trend toward better PSS scores in patients with T1-2 tumors versus T3-4 tumors, although this did not reach statistical significance. CONCLUSIONS Surgery and postoperative XRT offer relatively good LRC and moderate overall survival rates. Results, however, remain suboptimal, particularly with respect to the risk of DM and the functional outcome. These data provide a baseline for comparison with maturing results from multimodality trials in which radical surgery is not used in all patients with locally advanced oropharyngeal carcinoma.

[1]  G. Funk,et al.  Health states following head and neck cancer treatment: Patient, health‐care professional, and public perspectives , 1998, Head & neck.

[2]  A. Huang,et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.

[3]  A. Rademaker,et al.  Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing. , 1998, Archives of otolaryngology--head & neck surgery.

[4]  L. Tuason,et al.  A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results , 1997, Head & neck.

[5]  G. Weinstein,et al.  Combined surgery and postoperative radiotherapy for carcinoma of the base of tongue: Analysis of treatment outcome and prognostic value of margin status , 1997 .

[6]  E. Strong,et al.  Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue , 1997, Head & neck.

[7]  A. Munro An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. , 1995, British Journal of Cancer.

[8]  M. Zelefsky,et al.  Performance status after treatment for squamous cell cancer of the base of tongue--a comparison of primary radiation therapy versus primary surgery. , 1994, International journal of radiation oncology, biology, physics.

[9]  A S Garden,et al.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.

[10]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  M. Zelefsky,et al.  Long‐term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma , 1992, Cancer.

[12]  J. Fredrickson,et al.  Carcinoma of the tonsillar fossa: A nonrandomized comparison of irradiation alone or combined with surgery: Long‐term results , 1991, Head & neck.

[13]  K. A. Johnston,et al.  Quality of life bibliography and indexes. , 1990, Medical care.

[14]  M. List,et al.  A performance status scale for head and neck cancer patients , 1990, Cancer.

[15]  R. Gelber,et al.  Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. , 1987, Head & neck surgery.

[16]  J. Purdy,et al.  Carcinoma of the tonsillar fossa. A nonrandomized comparison of preoperative radiation and surgery or irradiation alone: Long‐term results , 1982, Cancer.

[17]  G. Fletcher,et al.  An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts , 1977, Cancer.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[20]  W. Mendenhall,et al.  Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue. , 1996, International journal of radiation oncology, biology, physics.

[21]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[22]  W. Hong,et al.  Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034. , 1992, International journal of radiation oncology, biology, physics.

[23]  J. Jacobs,et al.  Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. , 1992, International journal of radiation oncology, biology, physics.

[24]  J. Jacobs,et al.  Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. , 1991, International journal of radiation oncology, biology, physics.

[25]  Cella Df,et al.  Quality of life during and after cancer treatment. , 1988 .